Add BrightSurf on Google Email

Tiny CRISPR tool could help shred viruses

Rice University scientists developed a tiny CRISPR-Cas13 system to shred viruses by targeting RNA. The system's unique mechanism and three-dimensional structure were mapped using cryo-electron microscopy, allowing researchers to engineer it for improved precision and specificity.

SourceRice University·JournalNature Communications·TypeExperimental study·DateSep 27, 2023

Mayo Clinic researchers publish key findings about cell proteins to determine effectiveness of immunotherapy for colon cancer

Mayo Clinic researchers found that cells expressing PD-1 and PD-L1 within a certain distance of each other can predict the success of immunotherapy in patients with colorectal cancer. This spatial analysis may help select patients most likely to benefit from treatment, improving outcomes and minimizing unnecessary treatments.

SourceMayo Clinic·JournalClinical Cancer Research·DateAug 31, 2023

Gregarious locusts wear contrasting black-brown ‘clothes’ to warn predators

The study reveals the ability of organisms to achieve distinct body color patterns through precise control of pigment deposition. Gregarious locusts use their black-brown warning coloration to enhance aposematism by stimulating both visual and olfactory senses, facilitating recognition of conspecifics and maintaining large swarms.

SourceChinese Academy of Sciences Headquarters·JournalScience Advances·TypeObservational study·DateAug 23, 2023

Study raises possibility of immunotherapy treatment for ALS

Researchers at OHSU identified a type of monoclonal antibody that can slow the progression of amyotrophic lateral sclerosis (ALS) by modulating immune cells. The study used a mouse model and confirmed results in human brains affected by ALS, revealing a promising potential treatment for this fatal neurodegenerative disease.

SourceOregon Health & Science University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJul 31, 2023

Transcription factors contribute to subtypes of colorectal cancers

Researchers found that expression of transcription factors contributes to different subtypes of colorectal cancers. The degree of DNA methylation varies across tissue types, with some cancers having high and others low frequency of methylation gains. Studying transcription factor expression may help determine overall survival in patien...

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateJul 27, 2023

TTUHSC-TTU research collaboration leads to possible drug targets for Leishmaniasis

The study found that drug-resistant Leishmania parasites have distinct protein production profiles compared to sensitive parasites, suggesting a global reprogramming of protein synthesis. This pre-emptive adaptation enables the parasite to quickly respond to the presence of the drug and survive when it is absent.

SourceTexas Tech University Health Sciences Center·JournalNature Communications·TypeExperimental study·DateJun 22, 2023

Mutant KRAS regulates Y chromosome gene in colorectal cancer, driving metastasis and inhibiting anti-tumor immunity

A preclinical study has uncovered the role of Y chromosome gene KDM5D in regulating anti-tumor immune responses and promoting metastasis in male patients with KRAS-mutated colorectal cancer. The study reveals that mutant KRAS drives upregulation of KDM5D, leading to reduced cell adhesion and immune recognition by the immune system.

LincRNA paints a target on diseased tissues

Researchers have discovered a novel feature of long intergenic noncoding RNAs (lincRNAs) that can serve as markers indicating specific types of tissue. This finding has the potential to lead to highly specific disease treatments by targeting diseased tissues.

SourceUniversity of Tokyo·JournaliScience·TypeExperimental study·DateApr 26, 2023

Stay CALM when the heart skips a beat

Researchers at Kyoto University have discovered a genetic mutation that causes lethal arrhythmia in humans. The study found that a novel variant of the CALM2 gene produces robust arrhythmogenicity in human-induced pluripotent stem cell-derived cardiomyocytes.

SourceKyoto University·JournalCirculation Arrhythmia and Electrophysiology·TypeExperimental study·DateApr 13, 2023

Study unravels pathophysiological role of Dectin-1 in promoting colorectal cancer

A study led by Tokyo University of Science researchers identified Dectin-1's role in promoting colorectal cancer by enhancing PGE2 production and suppressing IL-22BP expression. The study used mouse models and clinical samples to validate the findings, which have immediate clinical implications for CRC patients.

SourceTokyo University of Science·JournalNature Communications·TypeExperimental study·DateApr 10, 2023

Impact of cortactin in cancer progression

Researchers discuss cortactin's impact on cancer progression by modulating the Wnt5a/ROR1 signaling pathway. Cortactin expression is found in various cancers, including breast and chronic lymphocytic leukemia, suggesting its potential role in promoting metastasis.

SourceImpact Journals LLC·JournalOncotarget·TypeCommentary/editorial·DateApr 4, 2023

OHIO diabetes researchers discover the potential of CIDEC protein to mitigate obesity-related cardiometabolic disease

A team of researchers from Ohio University discovered that CIDEC protein improves vascular and metabolic dysfunction, reducing insulin resistance and lipid levels in high-fat diet-induced mice. The study contributes to understanding the role of the vascular endothelium in regulating systemic metabolism.

SourceOhio University·JournalDiabetes·TypeExperimental study·DateMar 29, 2023

CNIO researchers propose biomarkers to select breast cancer patients who could benefit from denosumab treatment

Researchers have identified a biomarker that can select breast cancer patients who may benefit from denosumab treatment. The study found that tumors with high RANK protein expression are associated with poor prognosis and response to chemotherapy, suggesting that denosumab may be effective in hormone-receptor negative tumors.

SourceCentro Nacional de Investigaciones Oncológicas (CNIO)·JournalEMBO Molecular Medicine·TypeObservational study·DateMar 7, 2023

Lewis Katz School of Medicine at Temple University researchers find that new approach to boosting protein production could advance mRNA and protein-based medicines

A new approach to boosting protein production has been discovered, which could lead to the generation of a universal booster for protein production. The breakthrough centers on Exin21, a sequence that increases mRNA synthesis and stability and protein expression and secretion.

SourceTemple University Health System·JournalMolecular Therapy·DateFeb 20, 2023

Addition of antioxidants to cell cultures can enhance the production of monoclonal antibodies, promising therapeutics for a range of health conditions

The addition of antioxidants to cell cultures can improve the production of monoclonal antibodies by reducing oxidative stress and increasing cell viability. This has potential benefits for therapies targeting cancer and autoimmune diseases.

SourceSociety of Chemical Industry·JournalJournal of Chemical Technology and Biotechnology·TypeExperimental study·DateFeb 15, 2023

Pusan National University researchers uncover novel gene that regulates leukemia development and progression

Pusan National University researchers have identified a novel gene, SURF4, that regulates cell death and differentiation in acute myeloid leukemia (AML). The study found that suppressing SURF4 expression increases cell differentiation, cell death, and accumulation of ROS, leading to arrested tumor growth in mice.

SourcePusan National University·JournalCancer Communications·TypeExperimental study·DateJan 31, 2023